The latest at MBC Biolabs
The latest at MBC Biolabs
XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI
XPose Therapeutics is leveraging 3D structures of molecular fragments bound to drug targets to develop specific therapeutics.
Announcement of the 2020 Golden Ticket sponsored by Servier
2020 Servier Golden Ticket will be awarded in early September!
Biotech Startup Discovers Novel Hand Sanitizer for COVID-19, Offering Long-lasting 4+ Hours of Protection
IonLAST™, a novel hand sanitizer, kills germs on contact and, unlike common hand sanitizers, provides protection against their transmission for more than four hours after applying to skin.
With $30M and Stanford immunotherapy pioneer, biotech eyes one of the toughest brain diseases
A Stanford University spinout is joining the small army of biotech companies trying to find drugs for amyotrophic lateral sclerosis (ALS).
Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases
Tranquis Therapeutics are committed to the discovery and development of innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases.
Biotech startup announces R&D collaboration with major Japanese drug delivery company
The companies will evaluate novel formulations of drugs that have been notoriously difficult to formulate and deliver into the skin.
BioWorld: Drug developers’ Golden Ticket
BioWorld: Drug developers’ Golden Ticket, worth a lot more than a tour of a candy manufacturing plant
Announcing the Winners of the 2020 AbbVie Golden Ticket
Bacchus Therapeutics and PTM Therapeutics have each won a 2020 AbbVie Golden Ticket at MBC BioLabs.
Nitrome Biosciences Raises $38M Series A Financing
Read online article at BUSINESS WIRE San Francisco, Calif., April 21, 2020 /BUSINESS WIRE -- N [...]
2020 Amgen Golden Ticket Call for Proposals
AMGEN is accepting submissions for the Golden Ticket through June 24, 2020
Life Science Entrepreneurs Moving Into New Biotech Incubator
Home to 19 entrepreneurs already, up to 50 companies expected soon.
Third MBC BioLab Opens in Bay Area
Home to 19 entrepreneurs already, up to 50 companies expected soon.
CellFE Raises $3.6M in Seed Round
Read online article at YAHOO finance SAN CARLOS, Calif., Jan. 16, 2020 /PRNewswire/ -- CellFE, [...]
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics
And Its Tech Is Already Being Used Against Coronavirus Mammoth Biosciences is a MBC BioLabs [...]
The 2020 AbbVie Golden Ticket
Apply for the Golden Ticket until February 10, 2020.
How a biotech incubator is helping Big Pharma punch ‘golden tickets’ for startups
By Ron Leuty – Staff Reporter, San Francisco Business Times Dec 9, 2019, 2:16pm PST Read [...]
LogicInk appears on “The World According to Jeff Goldblum”, new series on Disney+
MBC BioLabs resident company, LogicInk, appeared on the Disney+ streaming platform, as par [...]
Announcing Winners of the 2019 Astellas Golden Ticket
AmbAgon Therapeutics and Gordian Biotechnology are the winners of the Astellas-sponsored "Golden Ticket Competition."
Astellas and MBC BioLabs Announce 2019 Golden Ticket Competition
Apply for the Golden Ticket until October 11, 2019.
Celgene and MBC BioLabs Announce 2019 Golden Ticket Competition
Apply for the Golden Ticket until August 16, 2019.
Co-founder and CEO of Mammoth Biosciences on Fortune’s 2019 40 Under 40
Trevor Martin Courtesy of Molly Jorgensen - Mammoth Biosciences Mammoth Biosciences came t [...]
An early taste of Wild Type Salmon
Wild Type’s lab-grown salmon product. Source: Wild Type Inc. Read original article by Lyd [...]
Announcing Winners of the 2019 AMGEN Golden Ticket
Regencor and Nitrome Biosciences have each been awarded an Amgen Golden Ticket to MBC BioLabs
Announcing Winner of the 2019 Servier Golden Ticket
The 2019 Servier Golden Ticket at MBC BioLabs has been awarded to Quartz Therapeutics.